Christian Elling
Senior Vice President, Managing Partner 麻豆社 BioCapital
Christian E. Elling heads the early stage biotech investment unit 麻豆社 BioCapital.
Christian E. Elling joined the Lundbeck Foundation in 2012 and heads the early-stage biotech investment unit 麻豆社 BioCapital. He received his M.Sc. in Biochemistry and his Ph.D. in Pharmacology from the University of Copenhagen, Denmark. Christian was previously co-founder, Vice President of Biology and Development, and later CEO of 7TM Pharma.
Member of the board of directors: Cytoki, IO Biotech, NMD Pharma, SNIPR Biome
Former member of the board of directors: AFYX Therapeutics, EpiTherapeutics, Inagen
